XML 23 R5.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Jan. 31, 2023
Income Statement [Abstract]      
Net sales and revenue $ 642,491 $ 833,384 $ 855,000
Cost of sales (includes $99.2 million, $117.0 million and $135.4 million with related parties for the years ended January 31, 2025, 2024 and 2023, respectively) 551,014 735,166 806,398
Gross profit 91,477 98,218 48,602
Selling, general and administrative expenses (27,148) (29,379) (22,827)
Equity in income of unconsolidated affiliates 9,385 13,921 8,745
Interest and other income, net 19,158 15,724 12,959
Income before income taxes 92,872 98,484 47,479
Provision for income taxes (21,386) (22,560) (9,542)
Net income 71,486 75,924 37,937
Net income attributable to noncontrolling interests (13,319) (14,989) (10,240)
Net income attributable to REX common shareholders $ 58,167 $ 60,935 $ 27,697
Weighted average shares outstanding – basic (in Shares) 17,636,000 17,482,000 17,638,000
Basic net income per share attributable to REX common shareholders (in Dollars per share) $ 3.3 $ 3.49 $ 1.57
Weighted average shares outstanding – diluted (in Shares) 17,636,000 17,576,000 17,638,000
Diluted net income per share attributable to REX common shareholders (in Dollars per share) $ 3.3 $ 3.47 $ 1.57